A study from Aarhus University has discovered that bimagrumab, a drug initially developed for muscle loss treatment, may also offer protection against osteoporosis in patients undergoing rapid weight loss through medication. Researchers found that bimagrumab not only increases bone tissue but also helps build muscle mass. This is especially pertinent as obesity rates continue to rise, with predictions of two billion people being classified as overweight by 2035. Understanding the long-term effects of such drugs is crucial for emphasizing health management amid the trend of weight loss therapies.
"We are the first to study how certain drugs affect bones, and the results show that bimagrumab can increase the amount of bone tissue while building muscle mass, and this could be very important for the many people currently taking weight loss medication."
"An estimated two billion people will be categorised as overweight by 2035, so it's also important that we research the drugs that come on the market for this particular patient group in order to better understand their long-term impact on the body."
Collection
[
|
...
]